Gilead stock falls as COVID-19 drug sales dwindle
April 29, 2021 at 16:27 PM EDT
Gilead Sciences Inc. reports a mixed quarter late Thursday, with sales below Wall Street expectations even as sales of its antiviral drug used to treat COVID-19 came in above forecast.
